CELZ MEXC RealStocks
Own real CELZ shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-17 14:14:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Creative Medical Technology Holdings, Inc. (CELZ) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $0.53, with a market capitalization of $4.01M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.49 to $4.72. This page covers its latest market performance, valuation, price trends and company information.
$4.01M | |
$0.54 | |
$0.55 | |
$0.49 | |
$0.52 | |
4.85K | |
663.90K | |
-- | |
$4.72 | |
$0.49 | |
-- | |
-- |
Creative Medical Technology Holdings, Inc. (CELZ) is trading at $0.53 in pre-market trading as of 2026-11-17 14:06:00, up 2.48% ($0.01) from the previous close of $0.52
Pre-market trading shows how investors are pricing CELZ before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Creative Medical Technology Holdings, Inc. (CELZ) moved from $0.62 to $0.53, representing a decline of 14.31% ($0.09).
The stock traded between $0.49 and $0.65 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 87.18 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 1.0%
CELZ is currently trading at $0.53, placing it 1.0% of the way from its 52-week low of $0.49 to its 52-week high of $4.72. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 4 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Creative Medical Technology Holdings, Inc. (CELZ) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to CELZ, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between CELZ shares and USD.
CELZ Shares to USD
1.00 CELZ shares = 0.533 USD
Calculations are estimates based on the latest available price and are for reference only.